These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3286384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V, Mela GS, Scalabrini P, Di Timoteo E, Magnolia MR, Celle G.
    Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.
    Savarino V, Mela GS, Scalabrini P, Fera G, Zentilin P, Sumberaz A, Celle G.
    Eur J Clin Pharmacol; 1988; 35(2):203-7. PubMed ID: 3191940
    [Abstract] [Full Text] [Related]

  • 4. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Mela GS, Celle G.
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [Abstract] [Full Text] [Related]

  • 5. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
    Lanzon-Miller S, Pounder RE, Ball SG, Dalgleish DJ, Coward J, Jackson AO.
    Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
    Watanabe Y, Tsumura H, Sasaki H, Morimoto T.
    Clin Ther; 1990 Mar; 12(6):534-46. PubMed ID: 2289221
    [Abstract] [Full Text] [Related]

  • 8. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G, Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P.
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V, Mela GS, Zentilin P, Scalabrini P, Bonifacino G, Gambaro P, Celle G.
    Digestion; 1989 May; 42(1):1-6. PubMed ID: 2568299
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer.
    Delchier JC, el Amine I, Roudot-Thoraval F, Elouaer-Blanc L, Lamarque D, Stanescu L.
    Aliment Pharmacol Ther; 1995 Apr; 9(2):191-6. PubMed ID: 7605861
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
    Alcalá Santaella R, Guardia J, Pajares J, Pique J, Pita L, Alvárez E, Castellanos P, Guarner L, Ortiz J, Pesquera R.
    Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
    [Abstract] [Full Text] [Related]

  • 13. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
    Thomson AB, Pinchbeck BR, Kirdeikis J, Zuk L, Marriage B, Prat A.
    Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA, Lanzon-Miller S, Pounder RE.
    Postgrad Med J; 1986 Apr; 62 Suppl 2():39-42. PubMed ID: 2890150
    [Abstract] [Full Text] [Related]

  • 15. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
    Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P, Celle G.
    Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
    Howden CW, Jones DB, Burget DW, Hunt RH.
    Gut; 1986 Sep; 27(9):1058-61. PubMed ID: 3758819
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer.
    Alcalá-Santaella R, Guardia J, Pajares J, Piqué J, Pita L, Alvárez E, Castellanos P, Guarner L, Ortiz J, Pesquera R.
    Digestion; 1989 Sep; 42(2):79-85. PubMed ID: 2670647
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
    Hartmann H, Fölsch UR.
    Digestion; 1988 Sep; 39(3):156-61. PubMed ID: 3061859
    [Abstract] [Full Text] [Related]

  • 20. Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.
    Delchier JC, Roudot-Thoraval F, Stanescu L, Deharvengt MC, Elouaer Blanc L.
    Gut; 1994 Jun; 35(6):750-4. PubMed ID: 8020798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.